BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 4149412)

  • 1. Interindividual differences in rates of drug oxidation in man.
    Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
    Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
    [No Abstract]   [Full Text] [Related]  

  • 2. Interindividual differences in drug oxidation: clinical importance.
    Sjöqvist F; von Bahr C
    Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic factors in hepatic drug oxidation.
    Kalow W; Inaba T
    Prog Liver Dis; 1976; 5():246-58. PubMed ID: 775542
    [No Abstract]   [Full Text] [Related]  

  • 4. Lead and polychlorinated biphenyls: effects on heme and drug metabolism.
    Alvares AP; Kappas A
    Drug Metab Rev; 1979; 10(1):91-106. PubMed ID: 118861
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytochrome P-450 and drug oxidation.
    Davies DS
    Biochem J; 1969 Dec; 115(5):23P-24P. PubMed ID: 4391248
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of drug metabolism by hydroxylated metabolites: cross-inhibition and specificity.
    Soda DM; Levy G
    J Pharm Sci; 1975 Dec; 64(12):1928-31. PubMed ID: 1206483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of inhibition of drug metabolic reactions.
    Gillette J; Sasame H; Stripp B
    Drug Metab Dispos; 1973; 1(1):164-75. PubMed ID: 4149379
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of hepatic drug oxidation and its relationship to individual differences in rates of oxidation in man.
    Davies DS; Thorgeirsson SS
    Ann N Y Acad Sci; 1971 Jul; 179():411-20. PubMed ID: 5285386
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in uraemic rabbits.
    Van Peer AP; Belpaire FM; Bogaert MG
    J Pharm Pharmacol; 1980 Feb; 32(2):135-6. PubMed ID: 6103036
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic and environmental factors affecting drug response in man.
    Vesell ES
    Fed Proc; 1972; 31(4):1253-69. PubMed ID: 4114107
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in rabbits with experimental renal failure.
    van Peer AP; Belpaire FM; Bogaert MG
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):346-7. PubMed ID: 708161
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug metabolism in uremia.
    Reidenberg MM
    Clin Nephrol; 1975; 4(3):83-5. PubMed ID: 1102176
    [No Abstract]   [Full Text] [Related]  

  • 13. Sex-dependent differences in drug metabolism in the rat. 3. Temporal changes in type I binding and NADPH-cytochrome, P-450 reductase during sexual maturation.
    Cohen GM; Mannering GJ
    Drug Metab Dispos; 1974; 2(3):285-92. PubMed ID: 4153061
    [No Abstract]   [Full Text] [Related]  

  • 14. Interindividual differences in pharmacokinetics in man: clinical importance.
    Sjöqvist F
    Panminerva Med; 1973 Apr; 15(4):99-112. PubMed ID: 4808047
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug displacement from protein-binding and redistributional interactions.
    McQueen EG
    Prog Biochem Pharmacol; 1974; 9():122-8. PubMed ID: 4140531
    [No Abstract]   [Full Text] [Related]  

  • 16. IV. Pharmacogenetics and drug toxicity. Variation of drug metabolism in animals and the prediction of drug action in man.
    Burns JJ
    Ann N Y Acad Sci; 1968 Jul; 151(2):959-67. PubMed ID: 4189972
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of steroids on drug metabolism in male and female rats.
    Stripp B; Menard RH; Zampaglione NG; Hamrick ME; Gillette JR
    Drug Metab Dispos; 1973; 1(1):216-23. PubMed ID: 4149385
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytochrome P-450: the effect of drugs and poisons].
    Chekman IS; Grinevich AI
    Farmakol Toksikol; 1984; 47(1):119-23. PubMed ID: 6705899
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of nifedipine on hepatic drug oxidation.
    Dickinson TH; Egan JM; Abernethy DR
    Pharmacology; 1988; 36(6):405-10. PubMed ID: 3420161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.